Skip to content
sellModerate cluster of 610b5-1 plan

Jen Hsun Huang sold $42M of NVDA

President and CEO at NVIDIA CORP. 225,000 shares at an average of $187.08, traded Sep 30, 2025, filed Oct 2, 2025.

Warning score
45
Value
$42M
225,000 shares
Holdings after
71,008,203
-0% from before
From 52-week low
+98%
low $94.07, close $186.13
From 52-week high
0%
high $186.13, as of Sep 30, 2025

Score components

  • Role
    CEO
    +25
  • Trade size
    $42.1M at market
    +25
  • Share of holdings sold
    Sold 0.3% of holdings
    0
  • Cluster
    6 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +7.2%, 3m -1.3%, 6m -6.1%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NVDAOct 9, 2026 · close 229.28
Since filing Oct 2, 2025: +21.7%SPY +17.5% · excess +4.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001197649-25-000042, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 30, 2025SOpen-market sale
Common Stock10b5-1
-7,167$182.19$1.3M71,226,036Oct 2, 2025
Sep 30, 2025SOpen-market sale
Common Stock10b5-1
-6,005$182.96$1.1M71,220,031Oct 2, 2025
Sep 30, 2025SOpen-market sale
Common Stock10b5-1
-7,809$184.14$1.4M71,212,222Oct 2, 2025
Sep 30, 2025SOpen-market sale
Common Stock10b5-1
-6,794$185.32$1.3M71,205,428Oct 2, 2025
Sep 30, 2025SOpen-market sale
Common Stock10b5-1
-36,108$186.11$6.7M71,169,320Oct 2, 2025
Sep 30, 2025SOpen-market sale
Common Stock10b5-1
-11,117$186.85$2.1M71,158,203Oct 2, 2025
Oct 1, 2025SOpen-market sale
Common Stock10b5-1
-9,486$184.58$1.8M71,148,717Oct 2, 2025
Oct 1, 2025SOpen-market sale
Common Stock10b5-1
-10,825$185.31$2.0M71,137,892Oct 2, 2025
Oct 1, 2025SOpen-market sale
Common Stock10b5-1
-14,577$186.72$2.7M71,123,315Oct 2, 2025
Oct 1, 2025SOpen-market sale
Common Stock10b5-1
-39,932$187.39$7.5M71,083,383Oct 2, 2025
Oct 1, 2025SOpen-market sale
Common Stock10b5-1
-180$188.01$34k71,083,203Oct 2, 2025
Oct 2, 2025SOpen-market sale
Common Stock10b5-1
-46,583$189.01$8.8M71,036,620Oct 2, 2025
Oct 2, 2025SOpen-market sale
Common Stock10b5-1
-25,662$189.77$4.9M71,010,958Oct 2, 2025
Oct 2, 2025SOpen-market sale
Common Stock10b5-1
-2,755$190.52$525k71,008,203Oct 2, 2025

Related signals

Other insiders at NVIDIA CORP and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
35Weak
NVDAsell 310b5-1
NVIDIA CORP
Timothy S. Teter
EVP, General Counsel and Sec
$6.8M
30,460 shares
-1%
75Notable
NVDAsell 3
NVIDIA CORP
Mark A Stevens
director
$300M
1,366,000 shares
-58%
42Moderate
NVDAsell 310b5-1
NVIDIA CORP
Colette Kress
EVP & Chief Financial Officer
$7.6M
34,918 shares
-4%
65Notable
NVDAsell 3
NVIDIA CORP
Mark A Stevens
director
$236M
1,022,239 shares
-30%
58Moderate
NVDAsell 2
NVIDIA CORP
Mark A Stevens
director
$411M
1,848,501 shares
-35%
28Weak
NVDAsell 210b5-1
NVIDIA CORP
Timothy S. Teter
EVP, General Counsel and Sec
$6.5M
30,000 shares
-1%
45Moderate
NVDAsell
NVIDIA CORP
Mark A Stevens
director
$186M
885,000 shares
-15%
60Notable
NVDAsell 3
NVIDIA CORP
Stephen C Neal
director
$3.3M
15,500 shares
-12%
60Notable
NVDAsell 3
NVIDIA CORP
Mark A Stevens
director
$221M
1,000,000 shares
-14%
21Weak
NVDAsell 310b5-1
NVIDIA CORP
John Dabiri
director
$134k
625 shares
-4%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.